NASDAQ: PRE - Prenetics Global Limited

Rentabilidade por seis meses: -1.83%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Prenetics Global Limited

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Prenetics Global Limited

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.

mais detalhes
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2022-05-18
ISIN KYG722451062
Industry Insurance
Sector Financials
Валюта usd
Валюта отчета usd
Сайт https://www.prenetics.com
Цена ао 3.56
Alteração de preço por dia: -1.49% (5.79)
Alteração de preço por semana: +1.04% (5.645)
Alteração de preço por mês: +28.75% (4.43)
Alteração de preço em 3 meses: +38.61% (4.115)
Mudança de preço em seis meses: -1.83% (5.81)
Mudança de preço por ano: -3.49% (5.91)
Mudança de preço em 3 anos: -42.33% (9.89)
Mudança de preço em 5 anos: 0% (5.7038)
Mudança de preço em 10 anos: 0% (5.7038)
Mudança de preço desde o início do ano: +26.75% (4.5)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 2.83 6
P/BV 0.2927 10
P/E 0 0
EV/EBITDA -0.4065 0
Total: 5.75

Eficiência

Nome Significado Nota
ROA, % -24.68 0
ROE, % -30.4 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 1.35

Obrigação

Nome Significado Nota
Debt/EBITDA -0.053 10
Total: 9.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 136.33 10
Rentabilidade Ebitda, % 158.9 10
Rentabilidade EPS, % 2964.52 10
Total: 10
Mais detalhes

Instituições Volume Compartilhar, %
Prudential PLC 684822 6.45
Aspex Management (HK) Ltd 346150 3.26
Nomura Holdings Inc. 193963 1.83
Aspire Private Capital, LLC 114 0
Bank of America Corporation 111 0
Wolverine Asset Management, LLC 1 0

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Vanguard Intermediate-Term Corporate Bond ETF 0.02 0.1996 4.17
Vanguard Intermediate-Term Bond ETF 0.01 -1.1 3.45
Schwab U.S. Aggregate Bond ETF 0 -1.22 3.65



Supervisor Cargo Pagamento Ano de nascimento
Mr. Hoi Chun Lo Chief Financial Officer N/A 1985 (40 anos)
Dr. Yung Ho Wong DPHIL Chief Technology Officer N/A 1982 (43 ano)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations N/A
Dr. Senthil Sundaram M.D. Chief Clinical Officer N/A 1974 (51 ano)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA N/A 1984 (41 ano)
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO N/A 1979 (46 anos)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer N/A 1974 (51 ano)
Mr. Walt Ling Chief Executive Officer of ACT Genomics N/A

Endereço: Hong Kong, Quarry Bay, Unit 701-706. K11 Atelier King’s Road - abrir no Google Maps, abrir mapas Yandex
Site: https://www.prenetics.com